Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Journal of Managed Care & Specialty Pharmacy|April 26, 2014
The prevalence of opioid-related major potential drug-drug interactions and their impact on health care costs in chronic pain patientsJoseph V Pergolizzi, Larry Ma, David R Foster, et al.
Clinical Pharmacology and Therapeutics|October 6, 2020
Transdermal Testosterone Attenuates Drug-Induced Lengthening of Both Early and Late Ventricular Repolarization in Older MenElena Tomaselli Muensterman, Heather A Jaynes, Kevin M Sowinski, et al.
Circulation. Cardiovascular Quality and Outcomes|May 8, 2014
Effectiveness of a clinical decision support system for reducing the risk of QT interval prolongation in hospitalized patientsJames E Tisdale, Heather A Jaynes, Joanna R Kingery, et al.
Circulation. Cardiovascular Quality and Outcomes|May 30, 2013
Development and validation of a risk score to predict QT interval prolongation in hospitalized patientsJames E Tisdale, Heather A Jaynes, Joanna R Kingery, et al.
Pharmacogenomics|March 22, 2023
Effects of oxycodone pharmacogenetics on postoperative analgesia and related clinical outcomes in children: a pilot prospective studyBlessed W Aruldhas, Sara K Quinney, Senthil Packiasabapathy, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 26, 2021
Pharmacokinetic modeling of R and S-Methadone and their metabolites to study the effects of various covariates in post-operative childrenBlessed W Aruldhas, Sara K Quinney, Brian R Overholser, et al.
Journal of Cardiovascular Electrophysiology|June 24, 2016
Efavirenz Inhibits the Human Ether-A-Go-Go Related Current (hERG) and Induces QT Interval Prolongation in CYP2B6*6*6 Allele CarriersAhmed M Abdelhady, Tyler Shugg, Nancy Thong, et al.
Pharmacotherapy|November 26, 2008
Pharmacokinetics of ibutilide in patients with heart failure due to left ventricular systolic dysfunctionJames E Tisdale, Brian R Overholser, Kevin M Sowinski, et al.
Pageof 6